Novel Concept Regenerative, Immune-Privileged, Bio-Stentgraft
|
|
- Leonard Bond
- 6 years ago
- Views:
Transcription
1 Novel Concept Regenerative, Immune-Privileged, Bio-Stentgraft Bruce M. Gordon, DO, FACC Advanced Heart Care, PA The Heart Hospital Baylor Plano, Texas Director, Cardiac Catheterization Lab, Denton, TX The Heart Hospital Baylor Denton
2 Disclosures Consultant: Medtronic Peytant Solutions Stockholder: Palmaz Scientific Scientia Cardio Access Total Wire 2
3 All Stents Elicit Foreign Bodies Reaction (FBR) FOREIGN BODIES Metal/Alloy (Nitinol, Sst., Chromium, Platinum) Synthetics Covering (Teflon, Dacron, Silicone, Urethane) Drug Carrier Coating (Urethane, Silicone) Pharmaceuticals (Paclitaxel, Rapamycin) Xenografts (Bovine, Porcine, Ovine, Equine - GVHD REACTIONS Inflammation Scar Tissue Thrombosis Restenosis Infection Allergic Migration Delamination 3
4 Regenerative Human Biomaterial - Amnion >100 years of Clinical Experience OP, Wound Repair, Surgery, Spine, Ob/Gyn, PD Immune-Privileged: Histocompatible antigens, survives in a hostile environments Anti-Thrombotic: PGI2/Anti-phospholipase-A2 peptides Anti-Inflammatory: tryptophan desert amino acid is depleted and inhibits lymphocyte proliferation Anti-Fibrosis/Anti-Scarring: contains tissue inhibitors regulate many crucial processes in inflammation and fibrotic processes 4
5 Regenerative Human Biomaterial Amnion (Cont.) Anti-Microbial: Human β3-defensin (HBD), peptides resists microbial colonization Non-Tumorigenic: AM-derived cellular cytokine solution (ACCS), a secreted product AM Multipotent Progenitor (AMP) cells Pro-Apoptosis: expresses active caspase-3 (cysteine peptidase) Compliant & Durable: AM structure & biological viability make it ideal for creating scaffolds use Tissue Engineering Readily Available: only living human sourced natural polymeric biomedical material obtained, issue free 5
6 Amnion as a Vascular Substitute Longitudinal Section of Amnion 5 & 48 wk Ovine Trials Human amnion - xenograft implants Juvenile ovine models Conduit external jugular Proximal & distal end-to-end anastomosis Longitudinal seam Results Demonstrated complete patency Normal endothelialization Without: Stenosis, Fibrosis, Intimal Thickening Thrombus Aneurysm, Leaks, Perforation Infections Inflammation, Foreign Body Rejection Properties of the Human Amnion for Potential use in Tissue Engineering; Niknejad H, et al.; European Cells and Materials Vo Discussion with Reviewers, pg Implantation of Amniotic Membrane as a Vascular Substitute in the External Jugular Vein of Juvenile Sheep, Niknejad H, et al, J Vasc. Surg. ;56(4): doi: /j.jvs
7 Amnion Applied to Stents Applications: Vascular, pulmonary, GI, etc. Superior engraftment: Immuneprivileged graft covering stent cells Facilitates endovascular healing: promotes endothelium, antiinflammatory Low profile: ~25 micron Versatile: Alloy & bio-absorbable scaffolding, catheter delivery FDA Status: Investigational device AmnioStent Peytant Solutions, Inc. Minneapolis, MN 7
8 POC Endovascular - Amnion Stent Graft AMNIOSTENT TRIAL Proximal & Distal Gross Pathology AmnioStent Ovine model Ilio-femoral artery Amnion covered, SE alloy stent Artery pre-conditioned prior to implant Low & High Magnified Cross Sections of AmnioStent RESULTS Fully patent Quiet - no thrombus, No scar tissue Healed & Bio-integrated Re-endothelialized Barrier to transmigrating neutrophils No infections No device migration 8
9 Amnion Covered Stent - Airway POC AMNION COVERED STENT TRIAL Ovine Models Amnion covered, alloy stents Trachea implants Proximal & Distal Gross Pathology Amnion Covered Stent AMNION RESULTS Cross section of Amnion Covered Stent Fully Patent Re-epithelialization Functional Ciliated Epithelium Mucociliary Escalator (MCE) Healed/Bio-Integrated No Inflammation, No Granuloma No Infections No Migration Preservation of normal architecture Barrier to transmigrating neutrophils 9
10 Summary Amniotic membrane a natural 1 solution to foreign body response Amniotic membrane is a promising development as a graft combined with a catheter delivered scaffolding Permanent: alloy AmnioStent Non-permanent: bio-absorbable AmnioStent 1 Simple solution - Occam s Razor 10
11 Thank You
12 Novel Concept Regenerative, Immune-Privileged, Bio-Stentgraft Bruce M. Gordon, DO, FACC Advanced Heart Care, PA The Heart Hospital Baylor Plano, Texas Director, Cardiac Catheterization Lab, Denton, TX The Heart Hospital Baylor Denton
EARLY INFLAMMATORY RESPONSES TO VASCULAR DEVICES
EARLY INFLAMMATORY RESPONSES TO VASCULAR DEVICES JAMES M. ANDERSON, MD, PhD DISTINGUISHED UNIVERSITY PROFESSOR DEPARTMENTS OF PATHOLOGY, MACROMOLECULAR SCIENCE, AND BIOMEDICAL ENGINEERING CASE WESTERN
More informationArch Repair with the Bolton Medical RelayBranch Thoracic Stent-graft system: Multicenter experience
Arch Repair with the Bolton Medical RelayBranch Thoracic Stent-graft system: Multicenter experience Joost van Herwaarden, MD, PhD University Medical Center, Utrecht Disclosure I have the following potential
More informationRSM. Indications For Use
NEXT GENERATION SOLUTIONS RSM PATRIOT-RSM Amniotic Allograft Membrane is a human placental-based tissue product. The membrane forms a protective covering over the wound while providing the key components
More informationA New Treatment Paradigm Outside-In
A New Treatment Paradigm Outside-In 2 2013 Mercator MedSystems OneMedForum Jan 8, 2013 Outside-In Response: Signal Amplification Signal convection Signal amplification Modified from Michel 2007, ATVB 3
More informationChristian Wissgott MD, PhD Assistant Director, Radiology Westküstenkliniken Heide
2-Year Results Of The Tack Optimized Balloon Angioplasty (TOBA) Trial For Fem- Pop Lesions Demonstrates Safety and Efficacy Of The Tack Endovascular System In Repairing Focal Post-PTA Dissections Christian
More informationManagement of In-stent Restenosis after Lower Extremity Endovascular Procedures
Management of In-stent Restenosis after Lower Extremity Endovascular Procedures Piotr Sobieszczyk, MD Associate Director, Cardiac Catheterization Laboratory Cardiovascular Division and Vascular Medicine
More informationLow profile TEVAR: is it an added value? Michel Bosiers, G. Torsello Münster
Low profile TEVAR: is it an added value? Michel Bosiers, G. Torsello Münster Disclosure Speaker name:...michel Bosiers... I have the following potential conflicts of interest to report: Consulting Employment
More informationAnatomical challenges in EVAR
Anatomical challenges in EVAR M.H. EL DESSOKI, MD,FRCS PROFESSOR OF VASCULAR SURGERY CAIRO UNIVERSITY Disclosure Speaker name:... I have the following potential conflicts of interest to report: Consulting
More informationTranscatheter Pulmonary Valve Replacement Update on progress and outcomes
Transcatheter Pulmonary Valve Replacement Update on progress and outcomes Barry Love, MD Director, Congenital Cardiac Catheterization Laboratory Mount Sinai Medical Center New York, New York Transcatheter
More informationWhich Stent Is Best for Various Femoropopliteal Anatomy? 2018 Pacific Northwest Endovascular Conference June 15-26, 2018 Seattle, WA
Which Stent Is Best for Various Femoropopliteal Anatomy? 2018 Pacific Northwest Endovascular Conference June 15-26, 2018 Seattle, WA Brian DeRubertis, MD, FACS Associate Professor of Surgery UCLA Division
More informationPathology of Cardiovascular Interventions. Body and Disease 2011
Pathology of Cardiovascular Interventions Body and Disease 2011 Coronary Artery Atherosclerosis Intervention Goals: Acute Coronary Syndromes: Treat plaque rupture and thrombosis Significant Disease: Prevent
More informationThe role of bioabsorbable stents in the superficial femoral artery What is going on? Frank Vermassen Ghent University Hospital Belgium
The role of bioabsorbable stents in the superficial femoral artery What is going on? Frank Vermassen Ghent University Hospital Belgium Disclosures Speaker name: Frank Vermassen I have the following potential
More informationWhat is the optimal time window for treating deep venous thrombosis? Acute vs subacute vs chronic
What is the optimal time window for treating deep venous thrombosis? Acute vs subacute vs chronic Peter A. Schneider, MD Chief of Vascular Therapy Kaiser Foundation Hospital Honolulu, Hawaii Disclosure
More informationIntervention for Lower Extremity PAD: When, why and what?! Robert F Cuff, MD FACS RVT RPVI
Intervention for Lower Extremity PAD: When, why and what?! Robert F Cuff, MD FACS RVT RPVI 1 Disclosures I have no financial disclosures related to this talk Objectives 1. Discuss indications for intervention
More informationSirolimus Nanocrystal Balloon Based Delivery for Coronary DES ISR
Sirolimus Nanocrystal Balloon Based Delivery for Coronary DES ISR DR. SAMEER I DANI Director, Department of Cardiology, Apollo Hospital & Life Care Institute (LIMSAR), Ahmedabad, India. IN STENT RESTENOSIS
More informationAV Access Technology and Innovation DEVICES CHANGING HOW WE THINK ABOUT VASCULAR ACCESS
AV Access Technology and Innovation DEVICES CHANGING HOW WE THINK ABOUT VASCULAR ACCESS Vascular Access New Technology What problem are you trying to solve for? Most common problem is inadequate outflow
More informationSafety and Feasibility of Intravascular Lithotripsy for Treatment of Common Femoral Artery Stenoses
Safety and Feasibility of Intravascular Lithotripsy for Treatment of Common Femoral Artery Stenoses Pr Marianne Brodmann, MD Univ. Klinik für Innere Medizin Medizinische Universtität Graz 1 Disclosure
More informationCase 37 Clinical Presentation
Case 37 73 Clinical Presentation The patient is a 62-year-old woman with gastrointestinal (GI) bleeding. 74 RadCases Interventional Radiology Imaging Findings () Image from a selective digital subtraction
More informationFish Skin Grafts Promote Superior Cell Ingrowth Compared to Amnion Allografts, Human Cadaver Skin and Mammalian Extracellular Matrix (ECM)
Fish Skin Grafts Promote Superior Cell Ingrowth Compared to Amnion Allografts, Human Cadaver Skin and Mammalian Extracellular Matrix (ECM) Christopher L. Winters, DPM American Health Network Indianapolis,
More informationProspective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access
Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access Disclosure Speaker name:... I have the following potential conflicts
More informationEndovascular Should Be Considered First Line Therapy
Revascularization of Patients with Critical Limb Ischemia Endovascular Should Be Considered First Line Therapy Michael Conte David Dawson David L. Dawson, MD Revised Presentation Title A Selective Approach
More informationThe present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio
The present status of selfexpanding and balloonexpandable tibial BMS and DES for CLI: Why and when to use Sean P Lyden MD Cleveland Clinic Cleveland, Ohio Disclosure Speaker name: Sean Lyden, MD I have
More informationClinically proven. ordering info. Vascular Intervention // Peripheral Self-Expanding Stent System/0.018 /OTW. Pulsar-18
140 μm thin struts Clinically proven 4F low profile Vascular Intervention // Peripheral Self-Expanding Stent System/0.018 /OTW Pulsar-18 Technical data / ordering info 140 μm thin struts - thinner than
More informationStep by step Hybrid procedures in peripheral obstructive disease. Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery
Step by step Hybrid procedures in peripheral obstructive disease Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Disclosure Speaker name: H.H. Staab I have the following
More informationDrug eluting stents and balloons in peripheral arterial disease A.T.O. ABDOOL-CARRIM UNIVERSITY OF WITWATERSRAND
Drug eluting stents and balloons in peripheral arterial disease A.T.O. ABDOOL-CARRIM UNIVERSITY OF WITWATERSRAND Drug eluting stents and balloons Endovascular treatment now becoming more popular for treatment
More informationTechnical Aspects for Treating AV Dialysis Fistulae with the IN.PACT DCB. Andrew Holden Auckland Hospital Auckland, New Zealand
Technical Aspects for Treating AV Dialysis Fistulae with the IN.PACT DCB Andrew Holden Auckland Hospital Auckland, New Zealand LINC 2017 26 th January 2017 Disclosure Speaker name: Andrew Holden I have
More informationMicromesh technology in carotid artery treatment what is next? Max Amor MD Clinique Louis Pasteur, Essey-Les-Nancy France
Micromesh technology in carotid artery treatment what is next? Max Amor MD Clinique Louis Pasteur, Essey-Les-Nancy France www.incathlab.com Disclosure Speaker name: Max Amor, MD.... I have the following
More informationEarly Clinical Results with the Valiant Mona LSA Branch Stent-Graft
Early Clinical Results with the Valiant Mona LSA Branch Stent-Graft Frank R. Arko III, MD Professor of Cardiovascular Surgery Director, Endovascular Surgery Co-Director, Aortic Institute Carolinas Medical
More informationHostile Proximal Neck: A New Conformable EVAR Device
Hostile Proximal Neck: A New Conformable EVAR Device Young-Guk Ko, M.D., Seoul, Korea Currently Available Devices for EVAR in Korea, 2018 Zenith Flex, Cook Endurant IIs, Medtronic INCRAFT, Cordis AFX2,
More informationTechnique and Tips for Complicated AAA Cases with Stent Graft
Technique and Tips for Complicated AAA Cases with Stent Graft Seung-Woon Rha, MD, PhD FACC, FAHA, FESC, FSCAI, FAPSIC Cardiovascular Center, Korea University Guro Hospital Mar 15, 2018 LINC AP 2018 Endoleak;
More informationIntroduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents
Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents Jesus Contreras, D.O. PGY-4 John Yasmer, D.O. Department of Radiology No Disclosures Objectives Introduce
More informationDevelopment Of DES Technology. HUO Yong,MD FACC Peking University First Hospital President-elect Chinese Society of Cardiology
Development Of DES Technology HUO Yong,MD FACC Peking University First Hospital President-elect Chinese Society of Cardiology Drug stents made in China Microport: Lepu: JW: Yinyi : Sinomed Yisheng Firebird
More informationHybrid Procedures for Peripheral Obstructive Disease - Step by Step -
Hybrid Procedures for Peripheral Obstructive Disease - Step by Step - Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Disclosure Speaker name:..holger Staab... I have
More informationVasile Goldiş Western University of Arad Faculty of Medicine, Pharmacy and Dental Medicine, Arad, Romania
ENDOVASCULAR TREATMENT FOR VASCULAR GRAFT RESTENOSIS Bogdan Totolici 1, Francisca Blanca Călinescu 1*, Ionel Droc 2, Carmen Neamţu 1 1 Vasile Goldiş Western University of Arad Faculty of Medicine, Pharmacy
More informationAccess More Patients. Customize Each Seal.
Access More. Customize Each Seal. The Least Invasive Path Towards Proven Patency ULTRA LOW PROFILE TO EASE ADVANCEMENT The flexible, ultra-low 12F ID Ovation ix delivery system enables you to navigate
More informationEndovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease
Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease Arash Bornak, MD FACS Vascular & Endovascular Surgery University of Miami Miller School of Medicine No disclosure BACKGROUND
More informationKlinikum Rosenheim Department of Diagnostic and Interventional Radiology
Klinikum Rosenheim Department of Diagnostic and Interventional Radiology Is Directional Atherectomy (Silverhawk Or Turbohawk) With DEB, Better Than DEB Alone: Based On The DEFINITIVE AR RCT: 1-Year Results
More informationDurable outcomes. Proven performance.
Durable outcomes. Proven performance. GORE EXCLUDER AAA Endoprosthesis GORE EXCLUDER Iliac Branch Endoprosthesis GORE EXCLUDER AAA Endoprosthesis The most-studied* EVAR stent graft designed for durable
More informationTOBA II 12-Month Results Tack Optimized Balloon Angioplasty
TOBA II 12-Month Results Tack Optimized Balloon Angioplasty William Gray, MD System Chief, Cardiovascular Division Main Line Health, Philadelphia, PA Dissection: The Primary Mechanism of Angioplasty Lesions
More informationDisclosure Statement. Objectives. Novel Therapies for Vascular Access Dysfunction: OptiflowDevice, Gene Therapy, and Sirolimus Wrap 2/29/2012
Novel Therapies for Vascular Access Dysfunction: OptiflowDevice, Gene Therapy, and Sirolimus Wrap Neointimal Hyperplasia Characteristic Lesion of Dialysis Access Dysfunction AVF Timmy Lee, M.D., M.S.P.H.,
More informationWound Healing Stages
Normal Skin Wound Healing Stages Stages overlap Chronic wounds are stalled in the inflammatory phase COLLAGEN MATURATION MATRIX METALLOPROTEINASES ENDOTHELIAL CELLS EPITHELIAL CELLS MATRIX PROTEINS FIBROBLASTS
More informationDrug- Coated Balloons for the SFA: Overview of Technology and Results
Drug- Coated Balloons for the SFA: Overview of Technology and Results NCVH Latin American 2015 Bogota, Colombia April 9-11, 2015 Brian G. DeRubertis, M.D. Associate Professor of Surgery Division of Vascular
More informationOptimizing Accuracy of Aortic Stent Grafts in Short Necks
Optimizing Accuracy of Aortic Stent Grafts in Short Necks Venkatesh Ramaiah, MD, FACS Medical Director Arizona Heart Hospital Director Peripheral Vascular and Endovascular Research Arizona Heart Institute
More informationTips and Tricks to Deliver a Stengraft to the Ascending Aorta
Tips and Tricks to Deliver a Stengraft to the Ascending Aorta Tilo Kölbel, MD, PhD University Heart Center University Hospital Eppendorf Hamburg, Germany Disclosures Research-grants, travelling, proctoring
More informationWhat Stent to Use? JASVINDAR SINGH MD, FACC
What Stent to Use? JASVINDAR SINGH MD, FACC ASSOCIATE PROFESSOR OF MEDICINE WASHINGTON UNIVERSITY IN ST. LOUIS DIRECTOR, CARDIAC CATHETERIZATION LAB BARNES-JEWISH HOSPITAL What Stent to Use? Jasvindar
More informationMid-term results of 300+ patients treated by endovascular aortic sealing (EVAS)
Mid-term results of 300+ patients treated by endovascular aortic sealing (EVAS) Jean-Paul P.M. de Vries Dept Vascular Surgery St. Antonius Hospital, Nieuwegein,The Netherlands On behalf of the DEVASS study
More informationRole of Covered Stents and Drug Eluting Balloons In Dialysis Access
Role of Covered Stents and Drug Eluting Balloons In Dialysis Access Joseph Habib, MD, FACS Assistant Professor Department of Surgery Division of Vascular and Endovascular Surgery University of Florida
More informationDurability of The Endurant Stent-Graft through 5 Years
Durability of The Endurant Stent-Graft through 5 Years Michel S. Makaroun MD Co-Director, UPMC Heart and Vascular Institute Professor and Chair, Division of Vascular Surgery University of Pittsburgh School
More informationUpdate on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee. Marianne Brodmann, MD Medical University Graz Graz, Austria
Update on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee Marianne Brodmann, MD Medical University Graz Graz, Austria Critical Limb Ischemia Infrapopliteal arterial disease is a leading source
More informationLOWERING THE PROFILE RAISING THE BAR
LOWERING THE PROFILE RAISING THE BAR INNOVATIVE LOW PROFILE. ADVANCED CLINICAL PERFORMANCE. The AFX TM Endovascular AAA System integrates anatomical fixation with an advanced delivery system and graft
More informationVascular Surgery and Transplant Unit University of Catania. Pierfrancesco Veroux
Vascular Surgery and Transplant Unit University of Catania Pierfrancesco Veroux Bologna-Palazzo dei Congressi, 23 Ottobre 2017 Disclosure Speaker name: Prof. Pierfrancesco Veroux I have the following potential
More informationTriVascular Ovation Prime Abdominal Stent Graft System
TriVascular Ovation Prime Abdominal Stent Graft System Science of the Seal O-Ring Sealing Technology O-Ring Sealing in Proven Engineering Solutions O-rings are designed to seal by blocking the flow of
More informationRegenerative Tissue Matrix in Treatment of Wounds
Regenerative Tissue Matrix in Treatment of Wounds Learning Objectives Differentiate between reparative and regenerative healing Review surgical techniques for applying a regenerative tissue scaffold to
More informationSecond Generation Drug Eluting Stents: From Inhibition to Healing
Second Generation Drug Eluting Stents: From Inhibition to Healing Mitchell W. Krucoff MD, FACC Professor of Medicine / Cardiology Duke University Medical Center Director, Cardiovascular Devices Unit Duke
More informationEVAS using Nellix in my practice Where are we today?
EVAS using Nellix in my practice Where are we today? Prof. dr. Michel MPJ Reijnen Department of Vascular Surgery, Rijnstate Hospital Arnhem Faculty of Science and Technology, University of Twente The Netherlands
More informationREBEL. Platinum Chromium Coronary Stent System. Patient Information Guide
REBEL Patient Information Guide REBEL PATIENT INFORMATION GUIDE You have recently had a REBEL bare metal stent implanted in the coronary arteries of your heart. The following information is important for
More informationIVUS Guided Case Review Case Performed by Frank R. Arko III, MD Charlotte, NC
IVUS Guided Case Review Case Performed by Frank R. Arko III, MD Charlotte, NC The opinions and clinical experiences presented herein are for informational purposes only. Dr. Arko is a paid consultant for
More informationResorbable particles: Are they the future?
Resorbable particles: Are they the future? Jafar Golzarian Professor of Radiology & Surgery Director, Division of Interventional Radiology University of Minnesota Why Resorbable? Common sense: Trend Patient
More informationThe Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice
The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice Dr Kate Steiner Consultant Interventional Radiologist East and North Hertfordshire NHS Trust Disclosure Speaker name: Dr
More informationRecommendations for Follow-up After Vascular Surgery Arterial Procedures SVS Practice Guidelines
Recommendations for Follow-up After Vascular Surgery Arterial Procedures 2018 SVS Practice Guidelines vsweb.org/svsguidelines About the guidelines Published in the July 2018 issue of Journal of Vascular
More informationLower Extremity Revascularization D oes Anesthesia Matter. Onaona Gurney PGY 4
Lower Extremity Revascularization D oes Anesthesia Matter Onaona Gurney PGY 4 Case Presentation 89yoM PMH of HTN, DM, HLD, BPH presented to podiatry with abscess to R great toe 5 weeks prior Drained by
More informationILLUMENATE FIH Direct DCB Cohort 12-Month Results
ILLUMENATE FIH Direct DCB Cohort 12-Month Results Stephan Duda Berlin Study Investigators: H. Schröder (PI), B. Lux, F. Rücker, M. Martorana, D. Meyer, H. Hartmann, S. Duda Disclosure Speaker name: S.
More informationBare Metal Stents vs Stent Grafts
Bare Metal Stents vs Stent Grafts ASDIN 12th Annual Scientific Meeting Phoenix, AZ, February 20, 2016 Dirk Hentschel, MD Director, Interventional Nephrology Brigham and Women s Hospital Disclosure Consultant:
More informationHow DCB drug dose effects vessel healing. Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA
How DCB drug dose effects vessel healing Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA Disclosure Statement of Financial Interest Speaker's name : Aloke, Finn, Gaithersburg I have the following
More informationPercutaneous Transapical Access for Thoracic Endovascular Repair
Percutaneous Transapical Access for Thoracic Endovascular Repair Atman P. Shah MD FACC FSCAI Co-Director, Hans Hecht Cardiac Catheterization Laboratory Clinical Director, Section of Cardiology Associate
More informationNew Fully Absorbable Patch Based Large Hole Vascular Closure Device
New Fully Absorbable Patch Based Large Hole Vascular Closure Device Jeffrey J. Popma, MD Beth Israel Deaconess Medical Center, Boston, MA Disclosure Statement of Financial Interest Over the past year,
More informationStents for The Common Femoral Artery: The Good, The Bad and The Ugly
Stents for The Common Femoral Artery: The Good, The Bad and The Ugly Salman Arain, MD, FACC Assistant Professor of Medicine - Cardiology University of Texas Health Sciences Center Houston Texas, USA Disclosure
More informationChallenging anatomies demand versatility.
Challenging anatomies demand versatility. The Distinct Advantages of Separating Seal and Fixation ANATOMICAL FIXATION Unlike proximal fixation designs, the AFX bifurcated unibody endograft allows for natural
More informationBC Vascular Day. Contents. November 3, Abdominal Aortic Aneurysm 2 3. Peripheral Arterial Disease 4 6. Deep Venous Thrombosis 7 8
BC Vascular Day Contents Abdominal Aortic Aneurysm 2 3 November 3, 2018 Peripheral Arterial Disease 4 6 Deep Venous Thrombosis 7 8 Abdominal Aortic Aneurysm Conservative Management Risk factor modification
More information5-YEAR SUPERIOR RESULTS. Compared to PTA and Zilver BMS 1. NOW WITH 140 mm LENGTH STENTS
SUPERIOR 5-YEAR RESULTS Compared to PTA and Zilver BMS 1 NOW WITH 140 mm LENGTH STENTS 1. Dake MD, Ansel GM, Jaff MR, et al. Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal
More informationVIRTUS: Trial Design and Primary Endpoint Results
VIRTUS: Trial Design and Primary Endpoint Results Mahmood K. Razavi, MD St. Joseph Cardiac and Vascular Center Orange, CA, USA IMPORTANT INFORMATION: These materials are intended to describe common clinical
More informationUtility of Image-Guided Atherectomy for Optimal Treatment of Ambiguous Lesions by Angiography
Utility of Image-Guided Atherectomy for Optimal Treatment of Ambiguous Lesions by Angiography Jon C. George, MD; Vincent Varghese, DO From the Deborah Heart and Lung Center, Browns Mills, New Jersey. ABSTRACT:
More informationPipeline Embolization Device
Pipeline Embolization Device The power to redefine aneurysm treatment. REDEFINE The Pipeline device redefines treatment for large or giant wide-necked aneurysms by reconstructing the parent artery and
More information2 Aortic Arch Debranching UCSF Vascular Symposium /14/16. J Endovasc Ther 2002;9:suppl 2; II98 105
How I Do It: Aortic Arch Debranching Exposures, Tunnels and Techniques Warren Gasper MD Assistant Professor of Surgery UCSF Vascular Surgery No disclosures 2 Aortic Arch Debranching UCSF Vascular Symposium
More informationExpanding to every demand: The GORE VIABAHN VBX Stent Graft
Expanding to every demand: The GORE VIABAHN VBX Stent Graft GORE, VIABAHN, and designs are trademarks of W. L. Gore & Associates. 2017 W. L. Gore & Associates, Inc. Program Faculty Martin Austermann, MD
More informationBilateral use of the Gore IBE device for bilateral CIA aneurysms and a first interim analysis of the prospective Iceberg registry
Bilateral use of the Gore IBE device for bilateral CIA aneurysms and a first interim analysis of the prospective Iceberg registry Michel MPJ Reijnen, MD, PhD Department of Vascular Surgery, Rijnstate Hospital
More informationAdventitial Drug Therapy for Critical Limb Ischemia
Adventitial Drug Therapy for Critical Limb Ischemia Ehrin J. Armstrong, MD, FACC University of Colorado School of Medicine VA Eastern Colorado Healthcare System Denver, Colorado, USA Disclosure Speaker
More informationTreating very short necks ( 4mm <10mm) using the Endurant stent graft + EndoAnchors: 1-year results and current insights
Treating very short necks ( 4mm
More informationACTIVATION OF T LYMPHOCYTES AND CELL MEDIATED IMMUNITY
ACTIVATION OF T LYMPHOCYTES AND CELL MEDIATED IMMUNITY The recognition of specific antigen by naïve T cell induces its own activation and effector phases. T helper cells recognize peptide antigens through
More informationPHARMACOLOGICAL TREATMENT OF ARTERIAL RESTENOSIS
PHARMACOLOGICAL TREATMENT OF ARTERIAL RESTENOSIS PACLITAXEL VS RAPAMYCIN Paclitaxel essentially freezes the microtubules that are in place during cell division. The cells cannot complete cell division
More informationDURABLE. CONSISTENT. SAFE. IN.PACT Admiral Drug-Coated Balloon
DURABLE. CONSISTENT. SAFE. Drug-Coated Balloon THE SCIENCE BEHIND THE OUTCOMES DCB has proven, long-term durable outcomes across multiple clinical trials, as well as across complex patient and lesion types.
More informationPatient Information Booklet
Patient Information Booklet Endovascular Stent Grafts: A Treatment for Thoracic Aortic Aneurysms Table of Contents Table of Contents Introduction 1 Anatomy of the Thoracic Aorta 2 What Is an Aneurysm?
More informationNew Cardiac Technologies. Melva Meminger MSN, RN, CCRN
New Cardiac Technologies Melva Meminger MSN, RN, CCRN What s New in Cardiac Care? Bigger is not always better: the new smaller Loop recorders First we burned and now we freeze (sometimes!): Cryoablation
More informationCorMatrix ECM Bioscaffold
CorMatrix ECM Bioscaffold REMODEL. REGROW. RESTORE. CorMatrix ECM Bioscaffold provides a natural bioscaffold matrix that enables the body s own cells to repair and remodel damaged cardio-vascular tissue.
More informationPopliteal Aneurysm: When is surgical therapy indicated? PROF. GRZEGORZ OSZKINIS
Popliteal Aneurysm: When is surgical therapy indicated? PROF. GRZEGORZ OSZKINIS Asymptomatic mass - 38-40%will develop symptoms at a rate of 14%/yr Intermittent claudic ation (chronic ischemia) - 25%-40%
More informationUltrasound-assisted catheter-directed thrombolysis: Does it really work? The BERNUTIFUL trial
Ultrasound-assisted catheter-directed thrombolysis: Does it really work? The BERNUTIFUL trial Rolf P. Engelberger Division of Angiology CHUV, Lausanne & Inselspital, Bern Switzerland Disclosure Speaker
More information2/28/2010. Speakers s name: Paul Chiam. I have the following potential conflicts of interest to report: NONE. Antegrade transvenous transseptal route
Transcatheter Aortic Valve Implantation Asian perspective Speakers s name: Paul Chiam Paul TL Chiam MBBS, MRCP, FACC I have the following potential conflicts of interest to report: NONE Consultant National
More informationChronic Total Occlusions. Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute
Chronic Total Occlusions Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute Financial Disclosures /see -tee-oh / abbr. Med. Chronic Total Occlusion,
More informationThe essentials for BTK procedures: wires, balloons, what else
A comprehensive approach to diabetic patient Tx The essentials for BTK procedures: wires, balloons, what else Dai-Do Do Clinical and Interventional Angiology Cardiovascular Department Disclosure Speaker
More informationClinical benefits on DES Patient s perspectives
Clinical benefits on DES Patient s perspectives Dr. Skyi Pang Vascular Surgeon Department of Surgery Pamela Youde Nethersole Eastern Hospital Hong Kong Disclosure Speaker name: Skyi Pang... I have the
More informationMesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future
Mesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future Cell Therapy 2014 Las Vegas, NV, USA Sulaiman Al-Hashmi, PhD Sultan Qaboos University Oman What are MSCs? Stem
More informationEndovascular Trauma Management. Thomas Larzon, MD, PhD Dep of Cardiothoracic and Vascular Surgery Örebro University Hospital, Sweden
Endovascular Trauma Management Thomas Larzon, MD, PhD Dep of Cardiothoracic and Vascular Surgery Örebro University Hospital, Sweden Medtronic Symposium, LINC 2016 Disclosures I have the following potential
More informationVenous interventions in DVT
Venous interventions in DVT Sriram Narayanan Chief of Vascular and Endovascular Surgery, Tan Tock Seng Hospital A/Prof of Surgery, National University of Singapore ANTI-COAGULATION LMWH Warfarin x 6m Acute
More informationTalent Abdominal Stent Graft
Talent Abdominal with THE Xcelerant Hydro Delivery System Expanding the Indications for EVAR Treat More Patients Short Necks The Talent Abdominal is the only FDA-approved device for proximal aortic neck
More informationEndovascular Repair o Abdominal. Aortic Aneurysms. Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida
Endovascular Repair o Abdominal Aortic Aneurysms Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida Disclosure Nothing to disclose. 2 Mr. X AAA Mr. X. Is a 70 year old male who presented to
More informationENCORE, a Study to Investigate the Durability of Polymer EVAR with Ovation A Contemporary Review of 1296 Patients
ENCORE, a Study to Investigate the Durability of Polymer EVAR with Ovation A Contemporary Review of 1296 Patients The Ovation System is approved to treat infrarenal abdominal aortic aneurysms and is not
More informationHistory of the Powerlink System Design and Clinical Results. Edward B. Diethrich Arizona Heart Hospital Phoenix, AZ
History of the Powerlink System Design and Clinical Results Edward B. Diethrich Arizona Heart Hospital Phoenix, AZ Powerlink System: Unibody-Bifurcated Design Long Main Body Low-Porosity Proprietary eptfe
More informationObjective assessment of current stent grafts: which graft for which lesion. Ludovic Canaud, MD, PhD Pierre Alric, MD, PhD Montpellier, France
Objective assessment of current stent grafts: which graft for which lesion Ludovic Canaud, MD, PhD Pierre Alric, MD, PhD Montpellier, France Conflict of interest: none 1 Introduction Different diseases
More informationProven Performance Through Innovative Design *
Proven Performance Through Innovative Design * Deliver Our Next Generation AV Covered Stent Results The COVERA Vascular Covered Stent builds upon proven technologies from the category leader in AV Access.
More informationSustained Release. Superior Results.
ELUVIA Drug-Eluting Vascular Stent System Sustained Release. Superior Results. Superiority determined in Post Hoc Superiority Analysis. 12-Month Primary Patency rate of 86.8% in the Eluvia arm (n=309)
More information